NIH-funded research R01 grant

Understanding how CUX1 influences blood stem cell development

Official title: Establishing CUX1 as a determinant of hematopoietic stem cell fate

Funded at University of Chicago · NIH-11003972 · Data updated 2026-11-12

This study is looking at how a gene called CUX1 affects blood stem cells, which are important for making blood cells, to help us understand better how changes in this gene might relate to blood disorders like leukemia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startDecember 1, 2022
Project endNovember 30, 2026
Funding year2025
Award (this year)$427,408
NIH project number5R01HL166184-03
Project IDNIH-11003972 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with blood disorders such as acute leukemia or myelodysplastic syndromes.

Less likely to help

Patients with non-hematological conditions or those without blood disorders may not benefit from this research.

What this research studies

This research investigates the role of the CUX1 gene in determining the fate of hematopoietic stem cells (HSCs), which are crucial for blood cell formation. By using a specially designed mouse model, researchers will measure CUX1 protein levels at a single-cell level during the development of these stem cells. The study aims to uncover how variations in CUX1 influence the behavior of blood stem cells, including their growth, self-renewal, and differentiation into various blood cell types. This could provide insights into conditions like acute leukemia and myelodysplastic syndromes.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating blood disorders by targeting the mechanisms that control blood stem cell fate.

How similar studies have gone: Previous research has shown promising results in understanding the role of transcription factors in stem cell behavior, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Mcnerney, Megan — University of Chicago
  • Study coordinator: Mcnerney, Megan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.